Atamyo doses first subject in Phase I/II muscular dystrophy therapy trial
France
NETRIS Pharma begins subject dosing in solid tumour therapy trial
The trial will assess the biological and clinical activity of NP137 as an add-on therapy in solid tumours patients.
BrainVectis gains approval for Phase I/II Huntington’s gene therapy trial
Innoskel enrols first patient to study collagen disorders in children
Pierre Fabre, EspeRare Foundation begin XLHED therapy trial
Sanofi, GSK announce positive Covid-19 vaccine trial data
MaaT Pharma reports positive data from Phase Ib blood cancer trial
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
